# Vedantra Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vedantra-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.vedantra.com
- Total disclosed funding: $3.3M
- Latest round: Series B (Nov 6, 2018)
- Investors on record: 2

## About

Founded in 2011 and based in Massachusetts, Vedantra Pharmaceuticals, Inc. is a company that develops vaccines for infectious diseases and cancer. The company uses nanotechnology-based approaches in the development of vaccines.

## Funding rounds

- Series B, Nov 6, 2018 — Thynk Capital
- Series A, Aug 3, 2012, $3.3M — Access BridgeGap Ventures

## Investors

- Access BridgeGap Ventures (https://capitalatlas.ai/funds/access-bridgegap-ventures) — Series A
- Thynk Capital (https://capitalatlas.ai/funds/thynk-capital) — Series B